News & Events
Latest Blog Posts
-
Treatment Options Expand for Some Advanced Ovarian Cancers
FDA has approved Elahere to treat advanced, platinum-resistant ovarian tumors that overproduce a protein called FR-α.
-
Scientists Link a Single Bacterium to Colorectal Cancer
The bacteria subtype fueled precancerous growths in mice and was often found in human tumor samples.
-
AI Tool Helps Predict Responses to Cancer Drugs
In a trial, the tool accurately predicted how individual cells would respond to single drugs and drug combinations.
Latest Press Releases
-
NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
An artificial intelligence tool called PERCEPTION developed by NCI researchers could one day be used to help doctors more precisely match patients with drugs that will be effective for their cancer.
-
For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life
Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors. Findings could potentially inform screening and long-term follow-up of those at greatest risk.
-
Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges
Interdisciplinary teams will address the following challenges: reducing cancer inequities, understanding the mechanisms of early-onset cancers, developing drugs for solid tumors in children, and broadening our knowledge about how T cells recognize cancer cells.
-
NIH to address dwindling clinical trial patient enrollment with centralized staffing support
The Virtual Clinical Trials Office aims to tackle the steep decline in participation in NCI-
funded cancer clinical trials by providing a centralized team of support staff working
remotely to assist with NCI-funded clinical trials activities.
-
NIH launches research network to evaluate emerging cancer screening technologies
The Cancer Screening Research Network (CSRN) will investigate how to identify cancers earlier, when they may be easier to treat, to ultimately save lives. In late 2024, CSRN plans to launch the Vanguard Study on Multi-Cancer Detection, a pilot study to inform the design of a larger trial of multi-cancer detection tests.
Media Resources
Cancer Currents Blog
Find news and updates on the latest cancer research.